Panelists

Home  >  Panelists  >  GAO Fu

GAO Fu

Character introduction

Professor George F. GAO obtained his PhD (DPhil) degree from Oxford University, UK and did his postdoc work in both Oxford University and Harvard University (with a brief stay in Calgary University). His research interests include enveloped viruses and molecular immunology. His group research is mainly focusing on the enveloped virus entry and release, esp. influenza virus interspecies transmission (host jump), structure-based drug-design and structural immunology. He is also interested in virus ecology, esp. the relationship between influenza virus and migratory birds or live poultry markets and the bat-derived virus ecology and molecular biology. He has published more than 500 refereed papers (Including papers in Cell, Nature, Science, The Lancet, New England Journal of Medicine, Proceedings of the National Academy of Sciences USA etc.), 10 books or book chapters and holds more than 25 UK, US and Chinese patents. His research has recently expanded on public health policy and global health strategy. He led the China CDC team in 2014 (From September to November, when the disease went to its sky-high level) to work in Sierra Leone for fighting against Ebola and his heroic role there has made a great deal for the field work. He works hard now for establishing an Africa-based center for pathogens and tropical diseases.

Gao is a member (academician) of Chinese Academy of Sciences (elected in 2013), a fellow of The Third World Academy of Sciences (TWAS, also known as The World Academy of Sciences) (elected in 2014), a fellow of American Academy of Microbiology (AAM, elected in 2015), an associate (foreign) member of EMBO (European Molecular Biology Organization) (elected in 2016), a fellow of AAAS (American Association for the Advancement of Science) (elected in2016), a fellow of RSE (Royal Society of Edinburgh) (elected in 2017), a fellow of AAS (African Academy of Sciences) (elected in 2017).

Gao is a recipient of several international and national awards, including Thompson Reuters Research Front Award (2008), TWAS Medical Prize (2012), Nikkei Asian Prize (Japan 2014), Tan Jiazhen (C. C. Tan) Grand Scientific Achievement Prize (2014) and Life Science Innovation Award (2008), HLHL S&T Advancement Award (2015), JP Wu-Paul Janssen (Medical and Pharmaceutical) Award (2015), Japanese Foreign Minister's Commencement (2015), Shulan Medical Sciences Award (2016) and the Gamaleya Medal (Russia 2018).

previous     first page

Next     LING Wen